Newsroom | 5243 results

Sorted by: Latest
Diabetes
-

Riassunto: WISE chiude un round di finanziamento di serie D da 30 milioni di euro sottoscritto in eccesso, accogliendo ENEA Tech and Biomedical come nuovo investitore strategico

MILANO--(BUSINESS WIRE)--WISE S.p.A., azienda innovativa di dispositivi medici specializzata in elettrodi impiantabili all'avanguardia per il neuromonitoraggio, la neuromodulazione e le interfacce cervello-computer (BCI, Brain-Computer Interface), oggi ha annunciato la chiusura di un round di finanziamento di serie D sottoscritto in eccesso, per un totale di 30 milioni di euro. Al round ha partecipato anche ENEA Tech and Biomedical, una fondazione italiana dedicata all'innovazione e al trasferi...
-

WISE clôture un tour de table de série D sursouscrite de 30 millions d'euros et salue l'entrée d'ENEA Tech and Biomedical comme nouvel investisseur stratégique

MILAN--(BUSINESS WIRE)--WISE S.p.A., société pionnière dans le domaine des dispositifs médicaux et spécialisée dans les électrodes implantables de pointe utilisés pour le neuromonitoring, la neuromodulation et les interfaces cerveau-ordinateur (ICO), a annoncé aujourd'hui la clôture réussie d'un tour de table de série D sursouscrit, d'un montant total de 30 millions d'euros. ENEA Tech and Biomedical, une fondation italienne dédiée à l'innovation et au transfert de technologies dans le secteur b...
-

Samenvatting: WISE rondt een overtekende Serie D-financieringsronde van 30 miljoen euro af en verwelkomt ENEA Tech e Biomedical als nieuwe strategische investeerder

MILAAN--(BUSINESS WIRE)--WISE S.p.A., een toonaangevend bedrijf op het gebied van medische hulpmiddelen dat gespecialiseerd is in geavanceerde implanteerbare elektroden voor neuromonitoring, neuromodulatie en hersen-computerinterfaces (BCI), heeft vandaag bekendgemaakt dat de overtekende Serie D-financieringsronde met een totaalbedrag van 30 miljoen euro succesvol is afgerond. Aan deze ronde nam ENEA Tech e Biomedical deel. Dit is een Italiaanse stichting die zich toelegt op innovatie en techno...
-

WISE schließt überzeichnete Serie-D-Finanzierungsrunde in Höhe von 30 Millionen Euro ab und begrüßt ENEA Tech und Biomedical als neuen strategischen Investor

MAILAND--(BUSINESS WIRE)--WISE S.p.A., ein wegweisendes Medizintechnikunternehmen, das sich auf fortschrittliche implantierbare Elektroden für Neuromonitoring, Neuromodulation und Gehirn-Computer-Schnittstellen (BCI) spezialisiert hat, gab heute den erfolgreichen Abschluss einer überzeichneten Serie-D-Finanzierungsrunde in Höhe von insgesamt 30 Millionen Euro bekannt. An der Runde beteiligte sich ENEA Tech and Biomedical, eine italienische Stiftung, die sich der Innovation und dem Technologietr...
-

Resumen: WISE cierra una ronda de financiación de serie D de 30 millones de euros, que ha tenido una demanda superior a la oferta, y da la bienvenida a ENEA Tech y Biomedical como nuevos inversores estratégicos

MILÁN--(BUSINESS WIRE)--WISE S.p.A., una empresa pionera en el sector de los dispositivos médicos especializada en electrodos implantables avanzados para la neuromonitorización, la neuromodulación y la interfaz cerebro-ordenador (BCI), ha anunciado hoy el cierre con éxito de una ronda de financiación de la serie D, que ha superado la demanda prevista, por un importe total de 30 millones de euros. A esta ronda se han sumado ENEA Tech and Biomedical, una fundación italiana dedicada a la innovació...
-

According to THE SAGE GROUP, the 2025 U.S. Prevalence of Peripheral Artery Disease (PAD) Exceeded 22 Million

BEAUFORT, S.C.--(BUSINESS WIRE)--Since 1995, the number of U.S. citizens with PAD has approximately doubled from 11 million to over 22 million. PAD is extremely costly with a current economic burden of $352-$694 billion, accounting for 7%-13% of National Health Expenditures.“Although PAD prevalence exceeds that of heart disease and stroke, compared to these other cardiovascular diseases, PAD remains underappreciated. PAD is a significant source of morbidity and mortality, as well as a major caus...
-

PHC Launches Cell-IQ® CO₂ Incubators with Active Humidity Control, Creating Critical Stability for Research Samples

WOOD DALE, Ill.--(BUSINESS WIRE)--PHC Corporation of North America (PHCNA), provider of PHCbi cell culture and sample preservation solutions across North America and Latin America, has introduced a new series of laboratory incubators featuring active hybrid humidification technology and enhanced contamination control. The new Cell-IQ® CO₂ incubator line is designed to deliver improved environmental stability for a wide range of cell culture applications. Maintaining precise and stable incubatio...
-

Cambrian Bio Presents Positive Human Translational Data for ATX-304, the First AMPK Network Activator, at the American Diabetes Association's 86th Scientific Sessions

NEW YORK--(BUSINESS WIRE)--Cambrian Bio presents positive Phase 1b data for ATX-304, the first AMPK Network Activator, at the ADA's 86th Scientific Sessions....
-

Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its plan to host a 2026 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company’s proprietary Targeted RNAi Molecule (TRiM™) platform. Each webinar in the Summer Series will focus on a specific therapeutic area and will feature presentations by Arrowhead team members about the company’s clinical candidates and externa...
-

WISE Closes Oversubscribed Series D Financing Round of €30 Million, Welcoming ENEA Tech and Biomedical as Strategic New Investor

MILAN--(BUSINESS WIRE)--WISE S.p.A., a pioneering medical device company specializing in advanced implantable electrodes for neuromonitoring, neuromodulation, and brain-computer interface (BCI), today announced the successful closing of an oversubscribed Series D financing round totaling €30 million. The round was joined by ENEA Tech and Biomedical, an Italian foundation dedicated to innovation and technology transfer in the biomedical sector, which enters WISE's investor base as a strategic pa...